Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
Overview
Authors
Affiliations
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273 or Pfizer-BNT162b2), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interaction and virus neutralization. In contrast, only Omicron but not the Delta variant escaped antibody recognition, most likely because only Omicron exhibits the mutation at E484A, a position associated with reduced recognition, resulting in further reduced neutralization (specificity escape). Nevertheless, the immunizations with RNA-based vaccines resulted in marked viral neutralization in vitro for all strains, compatible with the fact that Omicron is still largely susceptible to vaccination-induced antibodies, despite affinity- and specificity escape.
COVID-19 Variants and Vaccine Development.
Zhao Z, Bashiri S, Ziora Z, Toth I, Skwarczynski M Viruses. 2024; 16(5).
PMID: 38793638 PMC: 11125726. DOI: 10.3390/v16050757.
Osterman A, Krenn F, Iglhaut M, Badell I, Lehner A, Spath P Med Microbiol Immunol. 2023; 212(5):307-322.
PMID: 37561226 PMC: 10501957. DOI: 10.1007/s00430-023-00774-9.
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.
Kegler A, Drewitz L, Arndt C, Daglar C, Rodrigues Loureiro L, Mitwasi N Front Immunol. 2023; 14:1204543.
PMID: 37383226 PMC: 10293748. DOI: 10.3389/fimmu.2023.1204543.
Mahalingam G, Arjunan P, Periyasami Y, Dhyani A, Devaraju N, Rajendiran V Sci Rep. 2023; 13(1):8743.
PMID: 37253762 PMC: 10227802. DOI: 10.1038/s41598-023-35070-2.
Havranek B, Lindsey G, Higuchi Y, Itoh Y, Suzuki T, Okamoto T Commun Biol. 2023; 6(1):513.
PMID: 37173421 PMC: 10177734. DOI: 10.1038/s42003-023-04860-9.